Last update :
01/07/2022
Beta-blocker   Esmolol hydrochloride  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Brevibloc Austria, Belgium, Canada, Denmark, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, Iran, Ireland, Italy, Mexico, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United States of America
Cardesmo India
Crevimol Mexico
Esmocard Germany, India, Spain, Sweden
Esmolol Argentina, Chile, Iran, Switzerland, United States of America
Esocard India, Malaysia
Nevopax Mexico
Solmosol Mexico
Stability in solutions   Injection   Stability in solutions : Esmolol hydrochloride     
Container Solvent Concentration Temperature Storage Length of time References
Glass NaCl 0,9% or Glucose 5% 10 mg/ml 23°C-27°C Light
7 Day
204

Glass NaCl 0,9% or Glucose 5% 10 mg/ml 5°C Protect from light
7 Day
204

Glass Ringer’s lactate solution 10 mg/ml 23°C-27°C Light
7 Day
204

Glass Ringer’s lactate solution 10 mg/ml 5°C Protect from light
7 Day
204

Glass Sodium chloride 0,45% 10 mg/ml 23°C-27°C Light
7 Day
204

Glass Sodium chloride 0,45% 10 mg/ml 5°C Protect from light
7 Day
204

Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 mg/ml 23°C-27°C Light
7 Day
204

Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 mg/ml 5°C Protect from light
7 Day
204

Polyvinyl chloride Glucose 5% 10 & 20 & 30 mg/ml 20°C-24°C Light
48 Hour
137

Polyvinyl chloride Ringer’s lactate solution 10 mg/ml 23°C-27°C Light
7 Day
204

Polyvinyl chloride Ringer’s lactate solution 10 mg/ml 5°C Protect from light
7 Day
204

Polyvinyl chloride Sodium chloride 0,45% 10 mg/ml 23°C-27°C Light
7 Day
204

Polyvinyl chloride Sodium chloride 0,45% 10 mg/ml 5°C Protect from light
7 Day
204


  Mentions Légales